# Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)

Study · id `cardio:ct-nct07298993` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07298993](<https://clinicaltrials.gov/study/NCT07298993>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07298993

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 240 participants.

## Technical summary

Registry record NCT07298993. Randomized; quadruple masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2029-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT07298993, source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)
- Started: 2026-02-02 (actual) (ClinicalTrials.gov record NCT07298993, source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)
- Primary completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07298993, source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)
- Completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07298993, source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07298993, source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07298993-2026-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
- Acronym: DEPRESCRIBE
- Condition: Heart Failure
- Condition: HFpEF
- Condition: HFpEF - Heart Failure With Preserved Ejection Fraction
- Intervention (Drug): Placebo (matching)
- Intervention (Drug): Beta-blockers
- Lead sponsor: Weill Medical College of Cornell University
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH
- Collaborator: Kaiser Foundation Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry intervention name matches this record: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Weill Medical College of Cornell University (`cardio:org-weill-medical-college-of-cornell-university`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

## Provenance

Content hash: d8106feb8e8a4e88c661481e7c72524fcb4b774c55492e0c5de4f467fe789d09
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
